Devices › Device types
FDA product code GWF · class 2 · Neurology
Stimulator, electrical, evoked response: medical device reports filed with FDA
3,308 reports carry this product code, 1994–2026; 10 brands with a page.
- 3,308
- reports with this product code
- 0% of all MAUDE reports
- 1,007
- reports, 12 months to August 2026
- 1,120 in the 12 months before
- 96.1%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code GWF is FDA's classification for "Stimulator, electrical, evoked response" (neurology panel), a class 2 device. 3,308 medical device reports carry this product code, 0% of the MAUDE database, from January 1994 to August 2026.
1,007 reports arrived in the 12 months to August 2026, down 10% from 1,120 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.1%), injury (3.4%) and other (0.4%). 10 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Nim 4 0 Console | 1,422 | 528 | 0% | 97.4% |
| Patient Interface Nim4cpb1 Nim 4 0 | 278 | 122 | 0% | 100% |
| Nim-Eclipse Controller | 221 | 33 | 0% | 95.9% |
| Nim Vital Patient Interface 4 Channel | 158 | 123 | 0% | 100% |
| Nim-Eclipse Preamplifier | 153 | 35 | 0% | 99.3% |
| Nim 3 0 Interface | 32 | 48 | 0% | 99.4% |
| Nim 3 0 Mainframe International | 27 | 69 | 0% | 96.1% |
| Nim 3 0 Mainframe | 23 | 39 | 0% | 91.4% |
| Nim-Neuro 3 0 Mainframe | 11 | 38 | 0% | 97.2% |
| Bravo | 1 | 568 | 0% | 93.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Xomed | 3,028 | 91.5% |
| Nihon Kohden | 102 | 3.1% |
| Alphatec Spine | 17 | 0.5% |
| Natus Medical | 6 | 0.2% |
| Nuvasive | 3 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 1,637 | 49.5% |
| Inappropriate audible prompt/feedback | 302 | 9.1% |
| False negative result | 272 | 8.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 158 | 4.8% |
| Failure to power up | 134 | 4.1% |
| Computer software problema software problem | 113 | 3.4% |
| False positive result | 101 | 3.1% |
| Connection problema connection problem | 80 | 2.4% |
| Unable to obtain readings | 77 | 2.3% |
| Application program freezes or fails to launch | 64 | 1.9% |
| Incomplete or inadequate connection | 61 | 1.8% |
| Problem with software installation | 54 | 1.6% |
| Breakthe device broke | 52 | 1.6% |
| Device sensing problem | 48 | 1.5% |
| Signal artifact/noise | 48 | 1.5% |
| Battery problema problem with the battery | 43 | 1.3% |
| Electrical /electronic property probleman electrical or electronic problem | 39 | 1.2% |
| Failure to sense | 23 | 0.7% |
| Mechanical problema mechanical problem | 20 | 0.6% |
| Output problem | 20 | 0.6% |
Questions about stimulator, electrical, evoked response reports
What is product code GWF?
FDA's classification code for "Stimulator, electrical, evoked response", class 2, reviewed by the neurology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,308 reports through August 2026, 1,007 of them in the latest 12 months.
Which brands appear most often?
Nim 4 0 Console (1,422), Patient Interface Nim4cpb1 Nim 4 0 (278), Nim-Eclipse Controller (221), Nim Vital Patient Interface 4 Channel (158) and Nim-Eclipse Preamplifier (153). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.